NIO's Q4 deliveries fell short of expectations, highlighting sluggish growth in the competitive Chinese market. See why I'm ...

Organovo Holdings, Inc. (ONVO), a clinical-stage biotech firm focused on advancing innovative treatments for inflammatory bowel ...

Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease ...

Nio has been expanding its brand portfolio to help it address larger segments of the market and cater to more niche needs.

Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today ...

Dec. 11, 2024 — Investigators who previously found that a daily statin pill helps prevent heart attacks and strokes in people with HIV have now discovered a potential mechanism that may help to ...

Development items topped the list for the Town Board in December. At its meeting, the board approved a resolution to act as ...

NIO Inc.'s December delivery results and potential impact of EV subsidies on company's profitability and competitive edge in ...

A long-delayed travel plaza is finally scheduled to be constructed on Business Route 15 in Richmond Township according to a ...

China’s electric vehicle (EV) maker NIO Inc. NIO delivered 72,689 vehicles in the fourth quarter of 2024, up 45.2% year over ...

Yes, there is a market for stocks beyond the technology sector! A fifth intriguing stock that has the potential to double your money in 2025 is precious-metal miner SSR Mining ( SSRM 3.16%). Though ...

Chinese electric vehicle makers including Nio and Li Auto have followed market leaders Tesla and BYD in extending buying ...